全文获取类型
收费全文 | 4161篇 |
免费 | 213篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 174篇 |
妇产科学 | 62篇 |
基础医学 | 578篇 |
口腔科学 | 63篇 |
临床医学 | 246篇 |
内科学 | 654篇 |
皮肤病学 | 62篇 |
神经病学 | 353篇 |
特种医学 | 94篇 |
外科学 | 534篇 |
综合类 | 100篇 |
现状与发展 | 1篇 |
预防医学 | 228篇 |
眼科学 | 177篇 |
药学 | 546篇 |
中国医学 | 50篇 |
肿瘤学 | 417篇 |
出版年
2023年 | 27篇 |
2022年 | 69篇 |
2021年 | 116篇 |
2020年 | 67篇 |
2019年 | 80篇 |
2018年 | 109篇 |
2017年 | 74篇 |
2016年 | 114篇 |
2015年 | 95篇 |
2014年 | 137篇 |
2013年 | 197篇 |
2012年 | 308篇 |
2011年 | 297篇 |
2010年 | 180篇 |
2009年 | 163篇 |
2008年 | 240篇 |
2007年 | 241篇 |
2006年 | 204篇 |
2005年 | 192篇 |
2004年 | 180篇 |
2003年 | 147篇 |
2002年 | 122篇 |
2001年 | 67篇 |
2000年 | 77篇 |
1999年 | 58篇 |
1998年 | 41篇 |
1997年 | 21篇 |
1996年 | 28篇 |
1995年 | 23篇 |
1994年 | 22篇 |
1993年 | 23篇 |
1992年 | 52篇 |
1991年 | 53篇 |
1990年 | 38篇 |
1989年 | 60篇 |
1988年 | 45篇 |
1987年 | 38篇 |
1986年 | 34篇 |
1985年 | 42篇 |
1984年 | 33篇 |
1983年 | 30篇 |
1982年 | 16篇 |
1981年 | 20篇 |
1979年 | 37篇 |
1978年 | 19篇 |
1976年 | 14篇 |
1974年 | 11篇 |
1973年 | 17篇 |
1972年 | 16篇 |
1970年 | 11篇 |
排序方式: 共有4386条查询结果,搜索用时 31 毫秒
11.
Jones DL Weiss SM Chitalu N Villar O Kumar M Bwalya V Mumbi M 《American journal of infectious diseases》2007,3(4):169-176
An estimated 38.6 million persons globally are living with HIV, of whom over 1.1 million reside in Zambia. Of the 2 million cases in the US, 64% of new cases among women are among African Americans. Alcohol and drug use represents a significant risk factor for HIV transmission among both Zambians and African Americans. In addition, gender dynamics in both the US and Zambia promote transmission. This study examines two interventions targeting HIV risk behavior among HIV positive substance users, women in Miami, USA (the New Opportunities for Women (NOW) Project) and men in Lusaka, Zambia (the Partner Project). The study compares the efficacy of these two culturally tailored sexual behavior interventions provided in group and individual session formats. US and Zambian participants increased sexual barrier use and reduced substance-related sexual risk. Comparatively greater gains were made by higher risk Zambian males than US females in both group and individual conditions. Among lower risk participants, women in the group condition achieved and sustained the greatest comparative risk reductions. Results suggest that cost effective group HIV transmission risk reduction interventions for multiethnic individuals can be successfully implemented among both female and male drug and alcohol users in multinational settings. 相似文献
12.
Objective: To determine if drip infusion should be discontinued after full recovery of the patient from anaesthesia after minilaparotomy cholecystectomy in uncomplicated cases.Design: A randomised controlled clinical trial on 60 patients, from the waiting list, of cholelithiasis/cholecystitis operated by minilaparotomy cholecystectomy between November 1995 to March 1996. 30 patients did not receive postoperative IV drip infusion and in 30 patients 12–24 hours of standard drip transfusion was continued according to the current practice.Setting: Single Surgical Unit, SS Hospital, Banaras Hindu University, Varanasi, India.Main outcome measure: Recognition of clinical indication for continuation of. IV drip infusion after full recovery from anaesthesia.Results: In the cohorts of 30 patients each who were or were not given IV drip infusion after full recovery from anaesthesia following minilaparotomy cholecystectomy the observations on pulse rate, blood pressure, time to first voiding of urine and time to start first oral intake of fluids were identical. However postoperative urinary retention occured in 6 (20%) patients in whom the IV drip infusion was given.Conclusion: There is no clinical indication to continue IV drip infusion after full recovery from anaesthesia in patients operated for minilaparotomy cholecystectomy. 相似文献
13.
Platelet activating factor (PAF) stimulated aggregation and [32P]-phosphatidic acid (PA) production was compared in normal and diabetic human subjects in platelet rich plasma. The concentration of PAF for half maximal (50%) aggregation of normal and diabetic platelets was 50 nM and 8 nM, respectively. PAF stimulated [32P]-PA production (a metabolite of phospholipase C pathway) was also greater in the platelets from diabetic subjects. This [32P]-PA production was inhibited by the PAF receptor antagonists SRI-63441 and SRI-63675. When the levels of glycosylated hemoglobin (HbA1c) were compared with the PAF stimulated [32P]-PA production a significant relationship was observed. These studies have demonstrated for the first time that diabetic human platelets show hypersensitivity to PAF in both aggregation and [32P]-PA production compared to normal subjects. This may be a result of some modification in phospholipid turnover mechanism and is receptor mediated. Further, the relationship of the degree of aggregation and [32P]-PA production to the level of HbA1c suggest that the insulin deficiency may contribute to these effects. 相似文献
14.
S ArunabhDutta Gupta S Bal A K Sarda M Vijayraghavan N K Shukla M M Kapur 《The Japanese journal of surgery》1988,18(4):455-459
A case of extramedullary plasmacytoma in the soft tissues of the posterior chest wall of an 80-year old man is reported herein. Immunofluorescence study showed that the tumor cells produced IgG lambda. An M-component was also detected in the patient's serum by paper electrophoresis. Two months following the open biopsy done to establish diagnosis, the tumor underwent spontaneous regression and the M-component in the serum also disappeared. This is the first case report of spontaneous regression of an extramedullary plasmacytoma and the probable reasons for this spontaneous regression are discussed herein. 相似文献
15.
16.
Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans. 下载免费PDF全文
The steady-state pharmacokinetic interaction between nefazodone and cimetidine was evaluated in a three-period crossover study consisting of three treatments of 1 week duration with a 1 week washout between treatments. The 18 healthy, male study subjects received: nefazodone hydrochloride 200 mg twice daily (every 12 h) for 6 days; cimetidine 300 mg four times daily for 6 days; and 200 mg nefazodone hydrochloride twice daily + 300 mg cimetidine four times daily for 6 days. On day 7 of each treatment, only the morning dose was administered. Serial blood samples were collected for pharmacokinetic analysis after drug administration on day 7 of each treatment; blood samples for trough levels (Cmin) to assess attainment of steady state, were also collected just prior to the morning doses on days 2-7 of each study period. Plasma samples were assayed for cimetidine, and nefazodone and its metabolites hydroxynefazodone and m-chlorophenylpiperazine by specific, validated h.p.l.c. methods. Statistical analyses of Cmin data indicated that, regardless of treatment, steady state was achieved for cimetidine by day 2 and for nefazodone and its metabolites by day 3 of multiple dosing, and that there were no significant differences in Cmin levels between treatments. When nefazodone and cimetidine were co-administered for 1 week, no change in steady-state pharmacokinetic parameters for cimetidine, nefazodone or hydroxynefazodone was observed compared with each drug dosed alone.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
17.
18.
Protection against 7,12-dimethylbenzanthracene-induced tumour initiation by protein A in mouse skin.
S Kumar Y Shukla A K Prasad A S Verma P D Dwivedi N K Mehrotra P K Ray 《Cancer letters》1992,61(2):105-110
Protein A is an immunostimulating glycoprotein obtained from Staphylococcus aureus Cowan I. Its antitumour activity is proven in various tumour models. Its ability to provide protection against tumour initiation by the chemical carcinogen 7,12-dimethylbenzanthracene (DMBA) has been investigated in the present study using a mouse skin model of two-stage carcinogenesis. Protein A was administered intraperitoneally (1 microgram/animal 20 g body wt.) twice a week for 2 weeks, prior to initiation by DMBA. The promotion was performed by twice weekly applications of 12-O-tetradecanoyl phorbol-13-acetate (TPA) (3 or 5 micrograms/animal in 100 microliters acetone). Protein A provided significant protection to animals from DMBA-induced tumour initiation as was observed by the decrease in cumulative number of tumours, percent of animals developing tumours, number of tumours per animal and rate of tumour growth. Our data indicate that protein A has anticarcinogenic properties. 相似文献
19.
20.
R. K. S. Dogra R. C. Murthy A. K. Srivastava J. S. Gaur L. J. Shukla B. M. L. Varmani 《Archives of environmental contamination and toxicology》1996,30(2):292-297
An unexpected mortality of more than 300 cattle was investigated near a metal recovery factory located in a rural area of the Thane district of India. The factory was engaged in reclaiming lead, aluminium, tin, and zinc from discarded lead storage batteries and soft drink cans. The environmental samples (soil, leaves, grass, slag, water, and sediment), human blood and hair and animal samples (blood, urine, peritoneal fluid, liver, kidney, cow dung, ribs, and femur), collected for analysis revealed toxic levels of lead, cadmium, and chromium. Clinical examination of factory workers and school children revealed cough, fever, gastric problems, abdominal pain, skin lesions (scabies), and blue line on gums. Histopathological examination of animal tissues revealed chronic pathology with lead inclusion bodies in hepatocytes and renal tubules. Based on environmental, clinical, analytical, and histopathological observations, the mortality has been attributed to toxic levels of metals in the body and the malnourished status of the animals. 相似文献